These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14658952)

  • 1. Prolactin levels during long-term risperidone treatment in children and adolescents.
    Findling RL; Kusumakar V; Daneman D; Moshang T; De Smedt G; Binder C
    J Clin Psychiatry; 2003 Nov; 64(11):1362-9. PubMed ID: 14658952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.
    Findling RL; Aman MG; Eerdekens M; Derivan A; Lyons B;
    Am J Psychiatry; 2004 Apr; 161(4):677-84. PubMed ID: 15056514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders.
    Hellings JA; Zarcone JR; Valdovinos MG; Reese RM; Gaughan E; Schroeder SR
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):885-92. PubMed ID: 16379508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.
    Haas M; Karcher K; Pandina GJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):337-45. PubMed ID: 18759643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin levels in young children with pervasive developmental disorders during risperidone treatment.
    Masi G; Cosenza A; Mucci M
    J Child Adolesc Psychopharmacol; 2001; 11(4):389-94. PubMed ID: 11838821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.
    Snyder R; Turgay A; Aman M; Binder C; Fisman S; Carroll A;
    J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1026-36. PubMed ID: 12218423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.
    Anderson GM; Scahill L; McCracken JT; McDougle CJ; Aman MG; Tierney E; Arnold LE; Martin A; Katsovich L; Posey DJ; Shah B; Vitiello B
    Biol Psychiatry; 2007 Feb; 61(4):545-50. PubMed ID: 16730335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety, and tolerability.
    Reyes M; Croonenberghs J; Augustyns I; Eerdekens M
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):260-72. PubMed ID: 16768634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents.
    Migliardi G; Spina E; D'Arrigo C; Gagliano A; Germanò E; Siracusano R; Diaz FJ; de Leon J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1496-501. PubMed ID: 19706318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients.
    Croonenberghs J; Fegert JM; Findling RL; De Smedt G; Van Dongen S;
    J Am Acad Child Adolesc Psychiatry; 2005 Jan; 44(1):64-72. PubMed ID: 15608545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
    Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
    Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone and cognitive function in children with disruptive behavior disorders.
    Pandina GJ; Bilder R; Harvey PD; Keefe RS; Aman MG; Gharabawi G
    Biol Psychiatry; 2007 Aug; 62(3):226-34. PubMed ID: 17210137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
    Roke Y; van Harten PN; Boot AM; Buitelaar JK
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term antipsychotic treatment on prolactin.
    Staller J
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):317-26. PubMed ID: 16768639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
    Roke Y; Buitelaar JK; Boot AM; Tenback D; van Harten PN
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):432-9. PubMed ID: 23234586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.